Insmed (INSM) PT Raised to $43 at Morgan Stanley
Morgan Stanley analyst Jeffrey Hung raised the price target on Insmed (NASDAQ: INSM) to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
